Details for New Drug Application (NDA): 088356
✉ Email this page to a colleague
NDA 088356 describes HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25, which is a drug marketed by Ivax Pharms and is included in one NDA. Additional details are available on the HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25 profile page.
The generic ingredient in HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25 is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.
The generic ingredient in HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25 is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.
Summary for 088356
| Tradename: | HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25 |
| Applicant: | Ivax Pharms |
| Ingredient: | hydralazine hydrochloride; hydrochlorothiazide |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 25MG;25MG | ||||
| Approval Date: | Apr 10, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
